Hengehold Capital Management LLC Sells 491 Shares of Chemed Co. (NYSE:CHE)

Hengehold Capital Management LLC decreased its position in Chemed Co. (NYSE:CHE) by 52.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 454 shares of the company’s stock after selling 491 shares during the period. Hengehold Capital Management LLC’s holdings in Chemed were worth $240,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. UMB Bank n.a. raised its stake in shares of Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Trust Co. of Vermont acquired a new stake in shares of Chemed during the 4th quarter valued at about $34,000. American National Bank & Trust bought a new stake in Chemed in the third quarter valued at about $61,000. GAMMA Investing LLC lifted its stake in Chemed by 60.5% during the third quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock worth $83,000 after purchasing an additional 52 shares during the period. Finally, Quarry LP boosted its stake in Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after buying an additional 166 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Up 1.7 %

CHE stock opened at $550.99 on Friday. The business has a fifty day moving average of $544.24 and a 200-day moving average of $562.98. The company has a market cap of $8.29 billion, a P/E ratio of 27.84, a PEG ratio of 2.15 and a beta of 0.47. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $654.62.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same quarter in the previous year, the company posted $5.32 earnings per share. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. As a group, equities research analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date of this dividend was Monday, November 18th. Chemed’s dividend payout ratio is presently 10.11%.

Insider Buying and Selling at Chemed

In related news, EVP Spencer S. Lee sold 732 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total transaction of $421,353.84. Following the completion of the transaction, the executive vice president now owns 18,287 shares in the company, valued at approximately $10,526,362.94. The trade was a 3.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the sale, the chief executive officer now owns 101,735 shares in the company, valued at approximately $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 3.32% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CHE. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th. Royal Bank of Canada reduced their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.